1-5 of 5
Authors: Anthony Michalski
Sort by
Journal Article
MBRS-44. TIME, PATTERN AND OUTCOME OF MEDULLOBLASTOMA RELAPSE ARE ASSOCIATED WITH TUMOUR BIOLOGY AT DIAGNOSIS AND UPFRONT THERAPY: A COHORT STUDY Open Access
Rebecca Hill and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii405–iii406, https://doi.org/10.1093/neuonc/noaa222.553
Published: 04 December 2020
Journal Article
MBRS-60. THE ACTIONABLE GENOMIC LANDSCAPE OF RELAPSED MEDULLOBLASTOMA IS DEFINED BY MAINTENANCE AND ACQUISITION OF DRIVER EVENTS Open Access
Stacey Richardson and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii408, https://doi.org/10.1093/neuonc/noaa222.564
Published: 04 December 2020
Journal Article
LGG-43. CLINICAL EXPERIENCE OF BRAF AND MEK INHIBITOR THERAPY IN PAEDIATRIC GLIOMA Free
Patricia O’Hare and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i113–i114, https://doi.org/10.1093/neuonc/noy059.384
Published: 22 June 2018
Journal Article
ATRT-29. SUCCESS OF HIGH DOSE CHEMOTHERAPY IN INFANTS PRESENTING WITH ATYPICAL TERATOID RHABDOID TUMOURS (ATRT) Free
Patricia O’Hare and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i34, https://doi.org/10.1093/neuonc/noy059.027
Published: 22 June 2018
Journal Article
MEDU-06. NOVEL MOLECULAR SUBGROUPS IMPROVE CLINICAL CLASSIFICATION AND OUTCOME PREDICTION FOR CHILDHOOD MEDULLOBLASTOMA Free
Edward Schwalbe and others
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Page iv38, https://doi.org/10.1093/neuonc/nox083.157
Published: 31 May 2017
Advertisement
Advertisement